Co Q-10 400 mg

Co Q-10 400 mg

21st Century5.0 (58 ratings)
Format:Capsule Quantity: 30 Capsule(s) · 30 servings
Goals
$22.49 $0.74 per serving

Product analysis

49 out of 100

Co Q-10 400 mg may offer limited support for blood-vessel function in selected groups. Its unspecified preparation and limited serving value reduce confidence that the larger amount offers an advantage.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The CoQ10 form is unspecified, limiting a confident quality comparison. A large stated amount does not establish a superior delivery preparation.

Ingredient Transparency63

The CoQ10 amount is disclosed, helping compare servings. Its form remains unspecified, leaving delivery and preparation details unclear.

Value For Money40

CoQ10 offers limited value at the serving price. The larger declared amount does not establish a greater benefit that would justify the cost.

Customer Satisfaction76

Customer ratings are very positive, though the number of reviews is small. The limited feedback gives less confidence about wider customer experience.

Product Focus73

The clearest connection is limited support for blood-vessel and related markers in selected clinical groups. Normal cellular-energy roles do not establish more everyday energy or faster calorie burning.

Format
Capsule
Container
30 Capsule(s)
Per serving
$0.74
Customer rating
5.0 · 58 ratings
Report analysis

Goals

Energy
Impact
Moderate effect
A Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

CoQ10 at 400 mg connects to mitochondrial energy production, but fatigue evidence is limited and preparation-specific. The larger amount adds no further assessed contribution beyond the full comparison amount, and the redox form remains unidentified. Everyday energy benefits are uncertain.

How this product is rated for Energy

Ingredient fit93

1 ingredients relate to energy, giving a focused selection. The assessed amounts meet or closely approach the full comparison amounts.
Goal fit
1 ingredients relate to energy, giving a focused selection.
Dose adequacy
The assessed amounts meet or closely approach the full comparison amounts.

Pathways17

The clearest connection is mitochondrial energy production, with limited support in the saved findings.
Depth
The clearest connection is mitochondrial energy production, with limited support in the saved findings.
Breadth
The assessed contributions remain too limited to show meaningful breadth across the goal pathways.

Evidence27

Coenzyme Q-10 provides the strongest evidence contribution in the saved assessment, with practical benefits dependent on the relevant nutritional or trial context. Direct transfer of trial findings is limited by preparation matching for Coenzyme Q-10.
Evidence strength
Coenzyme Q-10 provides the strongest evidence contribution in the saved assessment, with practical benefits dependent on the relevant nutritional or trial context.
Studied preparation
Direct transfer of trial findings is limited by preparation matching for Coenzyme Q-10.

Formulation logic100

The relevant ingredients can contribute alone or have the partners required by the saved findings. No conflict was identified in the supplied checks. 1 of 1 relevant ingredients meet the saved minimum amount criterion.
Partner coverage
The relevant ingredients can contribute alone or have the partners required by the saved findings.
Conflicts
No conflict was identified in the supplied checks.
Effective doses
1 of 1 relevant ingredients meet the saved minimum amount criterion.
Study evidence
Heart Health
Impact
High effect
B Ingredient FitD PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

CoQ10 has limited evidence for changes in blood-vessel function, blood pressure and blood lipids in selected populations. The declared active amount provides a relevant comparison, but it does not establish that this product prevents cardiovascular events. Its ordinary CoQ10 identity also does not establish a superior delivery form.

How this product is rated for Heart Health

Ingredient fit80

Coenzyme Q-10 provides the main connection to heart health; other active ingredients broaden the formula beyond this goal
Goal fit
Coenzyme Q-10 provides the main connection to heart health; other active ingredients broaden the formula beyond this goal
Dose adequacy
The relevant amounts provide a partial contribution across the formula; higher amounts are not automatically more beneficial.

Pathways47

Endothelial nitric-oxide function is the strongest connection in the saved findings; this describes the ingredient roles, not a guaranteed effect.
Depth
Endothelial nitric-oxide function is the strongest connection in the saved findings; this describes the ingredient roles, not a guaranteed effect.
Breadth
The main areas represented are endothelial nitric-oxide function; other aspects have less support in this formula.

Evidence98

Coenzyme Q-10 provides the strongest relevant evidence here, with the population and benefit limits described above.
Evidence strength
Coenzyme Q-10 provides the strongest relevant evidence here, with the population and benefit limits described above.
Studied preparation
The contributing ingredient preparations match those recognized in the supplied comparison; this does not establish efficacy of the finished product.

Formulation logic100

The relevant ingredients do not depend on a missing partner in the supplied findings. No configured ingredient conflict was identified in the supplied findings.
Partner coverage
The relevant ingredients do not depend on a missing partner in the supplied findings.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The contributing ingredients have meaningful declared amounts for comparison, without proving a cardiovascular benefit.
Study evidence
Longevity
Impact
Moderate effect
A Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

CoQ10 at 400 mg supports cellular energy production and antioxidant defence. The saved assessment gives full dose support, but the higher amount does not resolve the limited applicability of skin-aging evidence from a particular preparation.

How this product is rated for Longevity

Ingredient fit93

The relevant ingredients give a focused contribution to this goal. The assessed amount receives full dose support in the saved findings.
Goal fit
The relevant ingredients give a focused contribution to this goal.
Dose adequacy
The assessed amount receives full dose support in the saved findings.

Pathways40

The strongest saved contribution relates to mitochondrial energy production, with moderate coverage. One reviewed pathway reaches the saved coverage threshold, leaving the contribution narrow.
Depth
The strongest saved contribution relates to mitochondrial energy production, with moderate coverage.
Breadth
One reviewed pathway reaches the saved coverage threshold, leaving the contribution narrow.

Evidence30

Coenzyme Q-10 provides the strongest effective ingredient evidence in the saved assessment; this concerns bounded outcomes rather than lifespan. The effective ingredient is not identified as the preparation used in the reviewed trials.
Evidence strength
Coenzyme Q-10 provides the strongest effective ingredient evidence in the saved assessment; this concerns bounded outcomes rather than lifespan.
Studied preparation
The effective ingredient is not identified as the preparation used in the reviewed trials.

Formulation logic100

The reviewed contributors can work independently or have their required partner in the supplied facts. No matched ingredient conflict was recorded in the saved assessment.
Partner coverage
The reviewed contributors can work independently or have their required partner in the supplied facts.
Conflicts
No matched ingredient conflict was recorded in the saved assessment.
Effective doses
1 of 1 assessed ingredients meet the saved minimum dose threshold.
Study evidence
Metabolism Support
Impact
High effect
A Ingredient FitD+ PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

Coenzyme Q-10 participates in mitochondrial electron transport, helping cells carry out normal energy processes. That role and findings on metabolic-control markers do not establish a routine increase in whole-body energy expenditure. The serving amount contributes to the saved comparison, but the supplied context does not support interpreting it as faster calorie burning or durable fat loss.

How this product is rated for Metabolism Support

Ingredient fit93

The contributing amounts reach the saved comparison benchmarks; this does not establish measured increases in energy expenditure.
Goal fit
The formula's contributing ingredients are not diluted by unrelated actives, though their roles may extend beyond this goal.
Dose adequacy
The contributing amounts reach the saved comparison benchmarks; this does not establish measured increases in energy expenditure.

Pathways54

The saved findings emphasize mitochondrial energy processes, which do not by themselves demonstrate increased whole-body energy expenditure.
Depth
The saved findings emphasize mitochondrial energy processes, which do not by themselves demonstrate increased whole-body energy expenditure.
Breadth
Mitochondrial energy and fat oxidation is the only area reaching the saved coverage threshold; broader effects are not established.

Evidence75

Coenzyme Q-10 leads the saved evidence finding; its normal metabolic or biomarker roles do not establish a routine rise in energy expenditure.
Evidence strength
Coenzyme Q-10 leads the saved evidence finding; its normal metabolic or biomarker roles do not establish a routine rise in energy expenditure.
Studied preparation
The contributing forms meet the saved preparation criteria; this does not transfer findings from other outcomes into a thermogenic benefit.

Formulation logic100

The contributing ingredients have no missing required partners or configured conflicts. Their amounts meet the saved minimum comparison threshold.
Partner coverage
No required partner is missing among contributing ingredients; this does not establish added thermogenesis from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied calculation.
Effective doses
All contributing ingredients meet the saved minimum amount threshold; this comparison threshold is not proof of a clinical thermogenic effect.
Study evidence
Inflammation
Impact
Highest effect
A- Ingredient FitD+ PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

CoQ10 in the ubiquinone form has limited evidence for lowering one inflammatory marker in statin-treated people with coronary artery disease. Other measured markers were unchanged, so this does not establish a broad clinical anti-inflammatory effect in general users. The 400 mg per serving is above the reviewed exposure, without establishing a larger response.

How this product is rated for Inflammation

Ingredient fit86

Coenzyme Q-10 anchors the fit, with amount or preparation limits reducing the attributable contribution.
Goal fit
The declared ingredients are concentrated on the inflammation-related roles considered here.
Dose adequacy
The CoQ10 amount exceeds the reviewed study exposure, so a larger contribution is not assumed.

Pathways52

The represented contribution centres on oxidative and mitochondrial stress. Other specified routes have limited coverage.
Depth
Oxidative and mitochondrial stress is the strongest represented route, with ingredient-specific limits on the expected clinical effect.
Breadth
One specified route reaches the required coverage, with little breadth across the others.

Evidence93

Coenzyme Q-10 provides the strongest included finding. Biomarker or selected-population findings do not establish broad clinical benefit.
Evidence strength
Coenzyme Q-10 anchors the evidence finding, with the described population and biomarker limitations still applying.
Studied preparation
The included preparations satisfy the supplied comparison, without removing their population or outcome limitations.

Formulation logic100

The included ingredients meet the amount and partner checks, with no specified conflict triggered.
Partner coverage
No required supporting partner is missing for the included ingredients.
Conflicts
None of the specified ingredient conflict checks was triggered.
Effective doses
The included ingredients meet the minimum amount comparison; it is not a proven clinical anti-inflammatory dose.
Study evidence
Cardiovascular Support
Impact
Highest effect
A Ingredient FitC PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 400 mg

CoQ10 has limited support for lipid, blood-pressure and blood-vessel markers in people with abnormal blood lipids. The declared 400 mg serving exceeds the 120 mg daily exposure in the supplied general CoQ10 study, but the larger amount does not establish proportionately greater benefit. The generic CoQ10 declaration also does not establish a superior delivery form or prevention of cardiovascular events.

How this product is rated for Cardiovascular Support

Ingredient fit93

The main ingredient or declared actives directly relate to the cardiovascular area represented here.
Goal fit
The main ingredient or declared actives directly relate to the cardiovascular area represented here.
Dose adequacy
The declared amount receives full recognition relative to the saved amount references; this does not establish a proven response at that exposure.

Pathways60

The contribution focuses on blood-vessel function.
Depth
The contribution focuses on blood-vessel function.
Breadth
One area reaches substantial coverage, so the contribution remains focused.

Evidence88

Declared CoQ10 matches the recognized active; evidence concerns selected markers in people with abnormal blood lipids.
Evidence strength
Declared CoQ10 matches the recognized active; evidence concerns selected markers in people with abnormal blood lipids.
Studied preparation
The saved findings recognize the eligible preparation or active declaration; this does not remove the ingredient-specific research limitations.

Formulation logic100

The recognized ingredients have no missing required partner or identified conflict in the supplied checks.
Partner coverage
The recognized ingredients can contribute independently or have their required partner; no additional benefit from combining them is established.
Conflicts
No conflict covered by the supplied checks was identified.
Effective doses
All ingredients retained for this check meet its minimum amount criterion, which is not a proven clinical threshold.
Study evidence

Ingredients

IngredientAmount per servingScore
Coenzyme Q-10
400 mg 37
Gluten Free Adults 18–50
Report overview
Coenzyme Q-10 · 400 mg OverallScore37
F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyD- Value
Each serving provides 400 mg of CoQ10, a larger amount. The saved facts do not identify whether it is ubiquinol or ubiquinone, limiting the form comparison.
How this ingredient is rated

Active Ingredient Quality & Bioavailability12

The saved facts do not identify the CoQ10 form, so its form-specific properties cannot be assessed.
Molecular Form: Ubiquinol vs. Ubiquinone
The saved facts do not identify the CoQ10 form, so its form-specific properties cannot be assessed.
Formulation & Absorption Enhancers
The saved facts record no qualifying liposomal, micellar, nano-emulsion or black pepper extract claim.

Dose, Safety & Label Transparency60

Each serving provides 400 mg of CoQ10, a larger amount.
Clinical Dosage Alignment
Each serving provides 400 mg of CoQ10, a larger amount.
Label Transparency & Fillers
The stated serving contains 400 mg of CoQ10, and the evaluated ingredient information records standard fillers.

Value40

A whole-product serving costs about $0.75.
Price Per Effective Serving
A whole-product serving costs about $0.75.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  7. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  8. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  9. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  10. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  11. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  12. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  13. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  14. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10
  16. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Karamali M; Gholizadeh M · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2022
    Randomized trial55 participantsInflammation forCoenzyme Q-10
  17. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
    Hou S; Tian Z; Zhao D; Liang Y; Dai S; Ji Q; Fan Z; Liu Z; Liu M; Yang Y · Molecular nutrition & food research · 2023
    Meta-analysis1,517 participants31 studies pooledInflammation forCoenzyme Q-10
  18. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M · Pharmacological research · 2020
    Meta-analysis509 participants9 studies pooledInflammation forCoenzyme Q-10
  19. Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
    Elsherif N; Shousha G; Sabri NA; Shawki MA · Immunopharmacology and immunotoxicology · 2026
    Randomized trial58 participantsInflammation forCoenzyme Q-10
  20. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
    Mantle D; Hargreaves I · Antioxidants (Basel, Switzerland) · 2020
    Narrative reviewLongevity forCoenzyme Q-10